Skip to main content
Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.
Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.
131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
Clinical features and outcomes in patients with secondary Ewing sarcoma.
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.
Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.
Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?
Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation.
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.